Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v4-EN | Version v3-EN | |
---|---|---|
Language | English | English |
Date Updated | 2021-03-01 | 2021-01-29 |
Drug Identification Number | 02141450 | 02141450 |
Brand name | 20% PROSOL | 20% PROSOL |
Common or Proper name | Amino Acid Injection 20% w/v | Amino Acid Injection 20% w/v |
Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
Ingredients | VALINE LYSINE HISTIDINE ISOLEUCINE LEUCINE PHENYLALANINE THREONINE DL-METHIONINE TRYPTOPHAN ALANINE GLYCINE ARGININE PROLINE GLUTAMIC ACID SERINE L-ASPARTIC ACID TYROSINE | VALINE LYSINE HISTIDINE ISOLEUCINE LEUCINE PHENYLALANINE THREONINE DL-METHIONINE TRYPTOPHAN ALANINE GLYCINE ARGININE PROLINE GLUTAMIC ACID SERINE L-ASPARTIC ACID TYROSINE |
Strength(s) | 1.44G 1.35G 1.18G 1.08G 1.08G 1G 0.98G 0.76G 0.32G 2.76G 2.06G 1.96G 1.34G 1.02G 1.02G 0.6G 0.05G | 1.44G 1.35G 1.18G 1.08G 1.08G 1G 0.98G 0.76G 0.32G 2.76G 2.06G 1.96G 1.34G 1.02G 1.02G 0.6G 0.05G |
Dosage form(s) | LIQUID | LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
Packaging size | 2L bag (4bags/case) (JB6186) | 2L bag (4bags/case) (JB6186) |
ATC code | B05BA | B05BA |
ATC description | I.V. SOLUTIONS | I.V. SOLUTIONS |
Reason for shortage | Requirements related to complying with good manufacturing practices. | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2021-01-28 | 2021-01-28 |
Actual start date | 2021-01-28 | 2021-01-28 |
Estimated end date | 2021-03-01 | 2021-03-31 |
Actual end date | 2021-03-01 | |
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Baxter Product Code JB6186. Product has been placed on allocation at 50% of historical usage. | Baxter Product Code JB6186. Product has been placed on allocation at 50% of historical usage. |
Health Canada comments |